HP-NAP of Helicobacter pylori: The Power of the Immunomodulation
- PMID: 35844568
- PMCID: PMC9277015
- DOI: 10.3389/fimmu.2022.944139
HP-NAP of Helicobacter pylori: The Power of the Immunomodulation
Abstract
The miniferritin HP-NAP of Helicobacter pylori was originally described as a neutrophil-activating protein because of the capacity to activate neutrophils to generate oxygen radicals and adhere to endothelia. Currently, the main feature for which HP-NAP is known is the ability to promote Th1 responses and revert the immune suppressive profile of macrophages. In this review, we discuss the immune modulating properties of the protein regarding the H. pylori infection and the evidence that support the potential clinical application of HP-NAP in allergy and cancer immunotherapy.
Keywords: HP-NAP; Helicobacter pylori; allergy; cancer; inflammation; therapy.
Copyright © 2022 Codolo, Coletta, D’Elios and de Bernard.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Davis MM, Brock AM, DeHart TG, Boribong BP, Lee K, McClune ME, et al. . The Peptidoglycan-Associated Protein NapA Plays an Important Role in the Envelope Integrity and in the Pathogenesis of the Lyme Disease Spirochete. PloS Pathog (2021) 17:e1009546. doi: 10.1371/journal.ppat.1009546 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
